IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 106 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,021,000 | – | 483,773 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 4,525,000 | $7,874,000 | 1.40% |
| DAFNA Capital Management LLC | 200,000 | $348,000 | 0.38% |
| HealthCor Management, L.P. | 3,270,000 | $5,690,000 | 0.30% |
| Baker Brothers Advisors | 5,865,000 | $10,205,000 | 0.14% |
| Spark Investment Management LLC | 152,500 | $262,000 | 0.06% |
| NATIXIS | 3,148,916 | $5,479,000 | 0.06% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 371,759 | $647,000 | 0.05% |
| LEAVELL INVESTMENT MANAGEMENT, INC. | 81,271 | $141,000 | 0.02% |
| TFS CAPITAL LLC | 118,232 | $206,000 | 0.01% |
| First Eagle Investment Management, LLC | 1,434,296 | $2,496,000 | 0.01% |